Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Wnt7a is a glycoprotein involved in embryonic development and the progression of different types of malignant tumors.
This study aimed to detect the level of Wnt7a expression in breast cancer and explore its role in the disease progression and prognosis. Methods: A total of 258 patients diagnosed with invasive ductal carcinoma of the breast were included in this study. Using tissue microarray and immunohistochemical staining, we evaluated the association between Wnt7a expression and clinicopathological parameters, and the prognostic value of Wnt7a. Results: Wnt7a expression was significantly correlated with estrogen receptor (ER) expression (odds ratio, 3.95; 95% confidence interval [CI], 1.99–7.80; p<0.001). On univariate and multivariate analyses, loss of Wnt7a expression was associated with poor disease-free survival (DFS) (multivariate hazard ratio [HR], 9.12; 95% CI, 1.80–46.09; p=0.008), but not with poor overall survival (OS). In the ER-positive group (n=114), loss of Wnt7a expression was an independent prognostic factor for shorter DFS (multivariate HR, 13.54; 95% CI, 1.11–165.73; p= 0.042) and OS (multivariate HR, 4.76; 95% CI, 1.29–17.61; p=0.019) on univariate and multivariate analyses. However, in the ER-negative group, there was no significant difference in DFS and OS according to Wnt7a expression. Conclusion: The loss of Wnt7a expression might be a meaningful factor in assessing DFS and OS, especially in ER-positive breast cancer.

참고문헌 (Reference)

1 Bikkavilli RK, "Wnt7a is a novel inducer of beta-catenin-independent tumor-suppressive cellular senescence in lung cancer" 34 : 5317-5328, 2015

2 Hirata T, "Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma" 33 : 2052-2060, 2015

3 Lyu J, "Wnt-7a up-regulates matrix metalloproteinase-12expression and promotes cell proliferation in corneal epithelial cells during wound healing" 280 : 21653-21660, 2005

4 Ohira T, "WNT7a induces E-cadherin in lung cancer cells" 100 : 10429-10434, 2003

5 Yoshioka S, "WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/beta-catenin pathway" 10 : 469-482, 2012

6 Lucas FR, "WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons" 192 : 31-44, 1997

7 Avgustinova A, "Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness" 7 : 10305-, 2016

8 Hirabayashi Y, "The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells" 131 : 2791-2801, 2004

9 Logan CY, "The Wnt signaling pathway in development and disease" 20 : 781-810, 2004

10 Goldhirsch A, "Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011" 22 : 1736-1747, 2011

11 Winn RA, "Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation" 280 : 19625-19634, 2005

12 Remmele W, "Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue" 8 : 138-140, 1987

13 Zhang XL, "Prognostic role of Wnt7a expression in ovarian carcinoma patients" 57 : 545-551, 2010

14 Ochoa-Hernández AB, "Peripheral Tlymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation" 12 : 60-, 2012

15 Liu Y, "Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer" 23 : 304-311, 2013

16 Jezierska A, "Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review" 15 : RA32-40, 2009

17 Dixon JM, "Long-term survivors after breast cancer" 72 : 445-448, 1985

18 Jemal A, "Global cancer statistics" 61 : 69-90, 2011

19 Kirikoshi H, "Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer" 21 : 895-900, 2002

20 Ramos-Solano M, "Expression of WNT genes in cervical cancer-derived cells: implication of WNT7A in cell proliferation and migration" 335 : 39-50, 2015

21 Peng C, "Expression and prognostic significance of Wnt7a in human endometrial carcinoma" 2012 : 134962-, 2012

22 조은윤, "Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period" 대한병리학회 51 (51): 69-78, 2017

23 Liu Z, "Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic Ras in human mammary epithelial cells" 7 : 39097-39107, 2016

24 Kondratov AG, "Alterations of the WNT7A gene in clear cell renal cell carcinomas" 7 : e47012-, 2012